Lyme disease: insights into the use of antimicrobials for prevention and treatment in the context of experience with other spirochetal infections.

Unanswered questions in the management of patients with Lyme disease or those who have had Ixodes tick bites include: Is antimicrobial therapy effective in preventing Lyme disease during the incubation period of the infection? Which oral agents are most effective in treatment? Are macrolides efficacious? For how long a time should antimicrobial therapy be given? Potentially useful insights into these questions can be gained by examining experience with other spirochetal infections. Using this information in conjunction with existing data from recent studies on Lyme borreliosis, tentative answers to these questions can be formulated. A short course of antibiotic therapy, perhaps even a single dose, can be anticipated to be effective in preventing Lyme disease after a tick bite. Beta-lactam drugs, such as amoxicillin, and tetracycline preparations, such as doxycycline, are the mainstays of oral therapy for treatment of active infection. Macrolides are less effective, but their utility is likely to be improved if they are given in maximal dosage. There is no convincing evidence for extending treatment of early Lyme disease beyond 14 days. There is also no evidence that longer therapy is more efficacious for other manifestations of Lyme disease, although this issue deserves further study.